UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W
Number of items: 322.

A

Adams, MJ; Donohoe, S; Mackie, IJ; Machin, SJ; (2001) Anti-tissue factor pathway inhibitor activity in patients with primary antiphospholipid syndrome. BRIT J HAEMATOL , 114 (2) 375 - 379.

Adeyemo, D; Imtiaz, F; Toffa, S; Lowdell, M; Wickremasinghe, RG; Winslet, M; (2001) Antioxidants enhance the susceptibility of colon carcinoma cells to 5-fluorouracil by augmenting the induction of the bax protein. CANCER LETT , 164 (1) 77 - 84.

Ahmed, F; Ings, SJ; Pizzey, A; Fahey, A; Blundell, M; Hardy, SJ; Thrasher, A; ... Yong, KL; + view all (2001) Cytokine exposure impairs short-term homing of CD34(+) cells in SCID/NOD mice: Influence of cell cycle status. BLOOD , 98 (11) 644A - 644A.

Al Saffar, N; Burrows, MG; Revell, PA; (2001) Immunopathological reaction to orthopaedic biomterial: The role of cytokines. In: Cracium, C and Ardelean, A, (eds.) Current problems in cellular and molecular biology. (pp. 37-50). : Cluk Napoca.

Ala, A; Standish, R; Khan, K; Prasad, N; Hillan, K; Dhillon, AP; Hodgson, H; (2001) Immmunohistochemical study of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) expression in primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC). Hepatology , 34 (4) 1404-.

Allen, AJ; Gale, RE; Harrison, CN; Machin, SJ; Linch, DC; (2001) Lack of pathogenic mutations in the 5'-untranslated region of the thrombopoietin gene in patients with non-familial essential thrombocythaemia. European Journal of Haematology , 67 (4) pp. 232-237.

Allen, AJR; Gale, RE; Harrison, CN; Machin, SJ; Linch, DC; (2001) Lack of pathogenic mutations in the 5 '-untranslated region of the thrombopoietin gene in patients with non-familial essential thrombocythaemia. EUR J HAEMATOL , 67 (4) 232 - 237.

Ancliff, PJ; Blundell, MP; Gale, RE; Liesner, R; Hann, IM; Thrasher, AJ; Linch, DC; (2001) Activating mutations in theWiskott Aldrich syndrome protein may define a sub-group of severe congenital neutropenia (SCN) with specific and unusual laboratory features. BLOOD , 98 (11) 439A - 440A.

Ancliff, PJ; Gale, RE; Hann, IM; Strobel, S; Linch, DC; (2001) Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. BLOOD , 98 (11) 439A - 439A.

Ardeshna, KM; Smith, P; Linch, DC; BNLI, ; (2001) The long-term impact of a watch and wait policy vs immediate systemic treatment for asymptomatic advanced stage indolent non Hodgkins lymphoma: Results of a British national lymphoma randomised trial. BRIT J CANCER , 85 2 - 2.

Arnold, J; Cohen, H; (2001) Erratum: Heparin-induced skin necrosis (British Journal of Haematology 111:4 (991-992)). British Journal of Haematology , 112 (4) 1091-. 10.1046/j.1365-2141.2001.02718.x.

Arulampalam, TH; Ledermann, J; Costa, DC; (2001) Asymptomatic patient with an increasing concentration of CEA. Lancet Oncol , 2 (3) 172-.

Ataman, OU; Bentzen, SM; Saunders, MI; Dische, S; (2001) Failure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced nonsmall-cell lung cancer: A competing risks analysis. British Journal of Cancer , 85 (8) pp. 1113-1118.

Aubert, G; Hassan-Walker, AF; Madrigal, JA; Emery, VC; Morte, C; Grace, S; Koh, MBC; ... Travers, PJ; + view all (2001) Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants. The Journal of Infectious Diseases , 184 (8) pp. 955-963.

B

BBC, 6ON; (2001) Thalidomide trial in lung cancer. UNSPECIFIED

BBC, N; (2001) 'My hope for Thalidomide cure'. UNSPECIFIED

BBC, NATIBFW; BBC, OTN; BBC, NB; (2001) Thalidomide is cancer weapon. UNSPECIFIED

BBC, R4IBRH; (2001) UNSPECIFIED UNSPECIFIED

Bagdi, E; Krenacs, L; Krenacs, T; Miller, K; Isaacson, PG; (2001) Follicular dendritic cells in reactive and neoplastic lymphoid tissues: A reevaluation of staining patterns of CD21, CD23, and CD35 antibodies in paraffin sections after wet heat-induced epitope retrieval. APPL IMMUNOHISTO M M , 9 (2) 117 - 124.

Bahadur, G; Whelan, J; Davies, MC; Ralph, D; (2001) Cancer patients, gametes, gonadal tissue, and the UK legal status. Reproductive BioMedicine Online , 2 (1) pp. 8-10. 10.1016/S1472-6483(10)62181-5.

Bahadur, G; Whelan, J; Ralph, D; Hindmarsh, P; (2001) Adolescent cancer patients sperm storage, consent and emotion. Human Reproduction , 16 (11) 2474-.

Bahadur, G; Whelan, J; Ralph, D; Hindmarsh, P; (2001) Gaining consent to freeze spermatozoa from adolescents with cancer: legal, ethical and practical aspects. Hum Reprod , 16 (1) pp. 188-193.

Bainbridge, JA; Revell, PA; Al Saffar, N; (2001) Costimulatory molecule expression following exposure to orthopaedic implants wear debris. Journal of Biomedical Materials Research Part A , 54 (3) pp. 328-334.

Bates, AW; (2001) The De monstrorum of Fortunio Liceti: a landmark of descriptive teratology. J Med Biogr , 9 (1) pp. 49-54. 10.1177/096777200100900112.

Bates, AW; (2001) A case of Roberts syndrome described in 1737. J MED GENET , 38 (8) 565 - 567.

Bates, AW; Smith, VV; (2001) Symptomatic diffuse colonic lipomatosis in Proteus syndrome. HISTOPATHOLOGY , 39 (1) 103 - 104.

Beck, S; (2001) Genome acrobatics: understanding complex genomes. DRUG DISCOV TODAY , 6 (23) 1181 - 1182.

Bench, AJ; Cross, NCP; Huntly, BJP; Nacheva, EP; Green, AR; (2001) Myeloproliferative disorders. In: BEST PRACT RES CL HA. (pp. 531 - 551). BAILLIERE TINDALL

Bentzen, SA; Saunders, MI; Dische, S; Bond, SJ; (2001) Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiotherapy And Oncology , 60 (2) pp. 123-135.

Bentzen, SM; Saunders, MI; Dische, S; Parmar, MK; (2001) Accelerated radiotherapy vs. chemoradiation in non-small cell lung cancer: quantifying the hazards. Radiother Oncol , 58 (1) pp. 91-92.

Berger, LA; Warwick, R; Mehta, A; (2001) Isolated Candida infection of the pterygoid muscles in a patient with Gaucher's disease. American Journal of Roentgenology , 176 1332-.

Bernassola, F; Salomoni, P; Melino, G; Pandolfi, PP; (2001) PML modulates p73-dependent transcription and apoptosis. BLOOD , 98 (11) 758A - 758A.

Boddy, AV; Griffin, MJ; Sludden, J; Thomas, HD; Fishwick, K; Wright, JG; Plummer, ER; ... Calvert, AH; + view all (2001) Pharmacological study of paclitaxel duration of infusion combined with GFR-based carboplatin in the treatment of ovarian cancer. CANCER CHEMOTH PHARM , 48 (1) 15 - 21.

Borràs, FE; Matthews, NC; Lowdell, MW; Navarrete, CV; (2001) Both lymphoid and myeloid subsets of dendritic cells are present in cord blood. European Journal of Immunogenetics , 28 (2) 259-.

Boshoff, C; (2001) Gammaherpesviral infections and neoplasia in immunocompromised populations. In: Smith, GL and Irving, WL and McCauley, JW and Rowlands, DJ, (eds.) NEW CHALLENGES TO HEALTH: THE THREAT OF VIRUS INFECTION. (pp. 213 - 232). CAMBRIDGE UNIV PRESS

Bowman, KJ; Newell, DR; Calvert, AH; Curtin, NJ; (2001) Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro. BRIT J CANCER , 84 (1) 106 - 112. 10.1054/bjoc.2000.1555.

Bownes, PJ; Hoskin, PJ; Ostler, P; (2001) Quality assurance for fractionated highdose rate afterloading brachytherapy of prostate cancer. In: (pp. S7-).

Bownes, PJ; Ostler, P; Hoskin, PJ; (2001) The effect of catheter movement on implant quality for fractionated high dose rate afterloading brachytherapy of prostate cancer. In: (pp. S30-).

Broome, ME; Allegretti, C; (2001) Adolescent cancer patients: sperm storage, consent and emotion. Hum Reprod , 16 (11) pp. 2473-2475.

Burcombe, RJ; Makris, A; Pittam, M; Lowe, J; Emett, J; Wong, WL; (2001) Evaluation of clinical complete response to neoadjuvant chemotherapy in primary breast cancer using (F-18)- fluorodeoxyglucose positron emission tomography. British Journal of Cancer , 85 p. 50.

Burcombe, RJ; Makris, A; Richman, PI; Pittam, M; Daley, F; Nobe, S; Wilson, GD; (2001) Evaluation of ER, PgR, HER2 and Ki67 as predictors of response to neoadjuvant chemotherapy for operable breast cancer. British Journal of Cancer , 85 p. 50.

Buscombe, R; Caplin, ME; Hepplewhite, J; Johnson, G; Bouloux, P; Meyer, T; Hochhauser, D; ... Hilson, AJW; + view all (2001) Use of radiolanreotice to treat somatostatin receptor positive tumours. European Journal of Nuclear Medicine , 28 (8) S480-.

Buscombe, R; Caplin, ME; Hepplewhite, J; Johnson, G; Bouloux, PL; Meyer, T; Hochhauser, D; ... Hilson, AJW; + view all (2001) Treating somatostatin receptor positive tumours with radiolanreotide. European Journal of Nuclear Medicine , 28 (8) OS253-.

C

Calder, JDF; Pearse, MF; Revell, PA; (2001) The extent of osteocyte death in the proximal femur of patients with osteonecrosis of the femoral head. Journal of Bone and Joint Surgery - Series A , 83B (3) pp. 419-422.

Cardigan, RA; Crook, M; Mackie, IJ; Machin, SJ; (2001) Plasma levels of factor XIIa and factor VIIa are increased but not related in primary hyperlipidaemia. BLOOD COAGUL FIBRIN , 12 (3) 187 - 192.

Carvalho, C; Pereira, HM; Ferreira, J; Pina, C; Mendonca, D; Rosa, AC; Carmo-Fonseca, M; (2001) Chromosomal G-dark Bands Determine the Spatial Organization of Centromeric Heterochromatin in the Nucleus. Molecular Biology of the Cell , 12 pp. 3563-3572.

Chakraverty, R; Rabin, N; Peggs, K; Robinson, S; Duncan, JR; Yong, K; (2001) Dermatomyositis and sarcoid-like reaction associated with multiple myeloma treated effectively by high-dose chemotherapy and autologous peripheral blood stem cell transplantation. BONE MARROW TRANSPL , 27 (11) 1215 - 1217.

Chase, JC; Dawson-Coates, JA; Haddow, JD; Stewart, MH; Haines, LR; Whitaker, DJ; Ken, ML; ... Pearson, TW; + view all (2001) Analysis of Kudoa thyrsites (Myxozoa: Myxosporea) spore antigens using monoclonal antibodies. Dis Aquat Organ , 45 (2) pp. 121-129. 10.3354/dao045121.

Chen, FE; Rawlings, E; Haque, T; Madrigal, JA; Amlot, P; (2001) Lytic antigen specificity of anti-EBV cytotoxic T cells arising in vivo during post-transplant lymphoproliferative disease parallels generation of anti-EBV specific CTL generated in vitro. Blood , 98 (11) 1688-.

Chitolie, A; Lawrie, AS; Mackie, IJ; Harrison, P; Machin, SJ; (2001) The impact of oral anticoagulant therapy, factor VIII level and quality of factor V-deficient plasma on three commercial methods for activated protein C resistance. BLOOD COAGUL FIBRIN , 12 (3) 179 - 186.

Clark, RE; Dodi, IA; Hill, SC; Lill, JR; Aubert, G; Macintyre, AR; Rojas, J; ... Madrigal, JA; + view all (2001) Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. Blood , 98 (10) pp. 2887-2893. Green open access
file

Clark, RE; Dodi, IA; Hill, SC; Lill, JR; Aubert, G; Macintyre, AR; Rojas, J; ... Madrigal, JA; + view all (2001) Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. Blood , 98 (10) pp. 2887-2893.

Clarke, SA; Revell, PA; (2001) Integrin expression at the bone/biomaterial interface. Journal of Biomedical Materials Research Part A , 57 (1) pp. 84-91.

Cohen, H; (2001) Lack of an association between the -455F/A b-fibrinogen gene polymorphism and pregnancy complications. In: (Proceedings) International society of thrombosis and haemostasis.

Cohen, H; (2001) Management of Jehovah's Witness patients with haematological problems. [Lecture]. Presented at: British society for haematology annual scientific meeting, Harrogate.

Cohen, H; (2001) SHOT: the future. In: (Proceedings) SHOT annual symposium.

Cook, DG; Cappuccio, FP; Atkinson, RW; Wicks, PD; Chitolie, A; Nakandakare, ER; Sagnella, GA; (2001) Ethnic differences in fibrinogen levels: The role of environmental factors and the beta-fibrinogen gene. AM J EPIDEMIOL , 153 (8) 799 - 806.

Cooke, S.P.; Boxer, G.M.; Lawrence, L.; Pedley, R.B.; Spencer, D.I.R.; Begent, R.H.J.; Chester, K.A.; (2001) A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor. Cancer Research , 61 (9) pp. 3653-3659.

Cooke, SP; Boxer, GM; Lawrence, L; Pedley, RB; Spencer, DIR; Begent, RHJ; Chester, KA; (2001) A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor : receptor complex. CANCER RES , 61 (9) 3653 - 3659.

Cox, ST; McWhinnie, AJ; Baker, FA; Stubbins, MJ; Allen, CJ; Holman, R; Madrigal, JA; (2001) Identification of HLA-A*2306. Tissue Antigens , 57 (1) pp. 73-75.

Cox, ST; McWhinnie, AJ; Baker, FA; Stubbins, MJ; Allen, CJ; Holman, R; Madrigal, JA; (2001) Identification of HLA-A*2306. Tissue Antigens , 57 (1) pp. 73-75.

Cox, ST; McWhinnie, AJ; Koester, RP; Heine, U; Holman, R; Madrigal, JA; Little, AM; (2001) Further diversity at HLA-A and -B loci identified in Afro- Caribbean potential bone marrow donors. Tissue Antigens , 57 (1) pp. 70-72.

Cox, ST; McWhinnie, AJ; Koester, RP; Heine, U; Holman, R; Madrigal, JA; Little, AM; (2001) Further diversity at HLA-A and -B loci identified in Afro- Caribbean potential bone marrow donors. Tissue Antigens , 57 (1) pp. 70-72.

Cox, ST; Tavarozzi, F; McWhinnie, A; Hoddinott, MA; Calvert, A; Baker, F; Madrigal, JA; (2001) HLA-B*4034 identified in a UK Caucasoid potential bone marrow donor. Immunogenetics , 53 (1) pp. 43-44.

Cox, ST; Tavarozzi, F; McWhinnie, A; Hoddinott, MA; Calvert, A; Baker, F; Madrigal, JA; (2001) HLA-B*4034 identified in a UK Caucasoid potential bone marrow donor. Immunogenetics , 53 (1) pp. 43-44.

Craddock, C; Spanswick, V; Mahendra, P; Sekhar, M; Hartley, JA; (2001) Repair of DNA interstarand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma. In: (pp. 41-).

Creaser, CS; Lill, JR; Bonner, PLR; Hill, SC; Rees, RC; Christmas, SC; Clark, R; ... Madrigal, JA; + view all (2001) Characterisation of HLA-A3 restricted peptide from the BCR-ABL fusion protein of the Philadelphia Chromosome using Nano-electrospray ion trap mass spectrometry. Advances in Mass Spectrometry , 15 pp. 637-638.

Cullen, MH; Billingham, LJ; Woodroffe, CM; Chetiyawardana, AD; Gower, NH; Joshi, R; Ferry, DR; ... Souhami, RL; + view all (2001) Mitomycin,Ifosfamide and cisplatin in unresectable non-small cell lung cancer: Effects on survival and quality of life. Classic Papers and Current Comments: Highlights of Lung Cancer Research , 6 (1) pp. 21-28.

Curtin, N; Barton, S; Batey, M; Calabrese, C; Calvert, H; Durkacz, B; Griffin, R; ... Webber, S; + view all (2001) Anti-cancer chemosensitization in vitro and in vivo by a novel potent poly(ADP-ribose) polymerase (PARP1) inhibitor, TBI-361. CLIN CANCER RES , 7 (11) 3740S - 3740S.

D

Daily, S; (2001) Hell drug for cancer.

Damien, E; Hing, K; MacInnes, T; Revell, PA; (2001) UNSPECIFIED In: (Proceedings) Enhancement of the bioactivity of hydroxyapatite implants invivo by growth factors: Effect of Insulin like growth factor -1 and -11. : London.

Damien, E; MacInnes, T; Hing, K; Revell, PA; (2001) Insulin like growth factor (IGF-I) increases the bioactivity of porous hydroxyapatite (PHA) in vivo in rabbits. The Journal of Pathology , 193 6A-6A.

Damien, E; MacInnes, T; Revell, PA; (2001) Effects of insulin like growth factors (IGF-I and IGF-II) during osteoinduction. Journal of Bone and Mineral Research , 16 (6) 6-.

Damien, E; MacInnes, T; Revell, PA; (2001) In vivo effect of insulin like growth factor-II (IGF-II) on de novo bone formation in the presence of hydroxyapatite in rabbit femur. BONE , 28 (5) S140-S140.

David, D; (2001) Thalidomide in trials to treat lung cancer. Daily Telegraph 4-.

David, F; (2001) Birth defects drug may return. Financial Times

Dhillon, AP; (2001) Variants of autoimmune liver disease: overlap and outlier syndromes. Annals of Contemporary Diagnostic Pathology , 201 (4) pp. 9-13.

Dickson, J; Bownes, P; Ostler, P; Hoskin, PJ; (2001) Combined external beam and brachytherapy boost for localised prostate cancer: A report of procedural complications and acute radiation toxicity. In: (pp. p. 89).

Donohoe, S; Mackie, IJ; Isenberg, D; Machin, SJ; (2001) Anti-prothrombin antibodies: Assay conditions and clinical associations in the anti-phospholipid syndrome. British Journal of Haematology , 113 (2) pp. 544-549. 10.1046/j.1365-2141.2001.02716.x.

Donohoe, S; Mackie, IJ; Isenberg, D; Machin, SJ; (2001) Anti-prothrombin antibodies: assay conditions and clinical associations in the anti-phospholipid syndrome. BRIT J HAEMATOL , 113 (2) 544 - 549.

Du, MO; Liu, H; Diss, TC; Hamoudi, RA; Ye, H; Dupin, N; Oksenhendler, E; ... Isaacson, PG; + view all (2001) KSHV infects monotypic (IgM lambda) but polyclonal naive B- cells in Castleman's disease and associated lymphoproliferative disorders. The Journal of Pathology , 193 3A-3A.

Du, MO; Liu, H; Diss, TC; Hamoudi, RA; Ye, H; Dupin, N; Oksenhendler, E; ... Isaacson, PG; + view all (2001) KSHV infects monotypic (IgM lambda) but polyclonal naive B-cells in Castleman's disease and associated lymphoproliferative disorders. J PATHOL , 193 3A - 3A.

Du, MQ; Liu, H; Diss, TC; Ye, H; Hamoudi, RA; Dupin, N; Meignin, V; ... Isaacson, PG; + view all (2001) Kaposi sarcoma-associated herpes virus infects monotypic (IgMl) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. BLOOD , 97 (7) pp. 2130-2136.

E

Ellis, PE; Wong, TF; Rolfe, KJ; Crow, J; Reid, WMN; MacLean, AB; Perrett, CW; (2001) p53 and Ki67 expression in Paget's disease of the vulva with or without invasive disease. In: (pp. 156-).

Ellis, PE; Wong Te Fong, LF; Rolfe, KJ; Crow, JC; MacLean, AB; Perrett, CW; (2001) An examination of the role of VEGF-A and PD-ECGF/TP in Pagets disease of the vulva and the breast. Anticancer Research , 21 pp. 1632-1633.

Ezoe, S; Mtsumura, I; Mizuki, M; Kawasaki, A; Machii, T; Yamamoto, M; Enver, T; (2001) Roles of P21(WAF1) and P27(KIP1) in GATA-2-induced growth suppression of hematopoietic cells. BLOOD , 98 (11) 759A-759A.

F

Farnie, G; Atkins, H; Calvert, AH; Curtin, NJ; Golding, BT; Griffin, RJ; Hardcastle, I; ... Lunec, J; + view all (2001) Inhibiting the MDM2-p53 interaction using low molecular weight compounds. BRIT J CANCER , 85 81 - 81.

Flynn, AA; Green, AJ; Pedley, RB; Boxer, GM; Boden, RAB; R, HJ; (2001) A mouse model for calculating the absorbed beta dose, from 131I and 90Y labelled immunoconjugates, including a method for dealing with heterogeneity in kidney and tumour. Radiation Research , 156 pp. 28-35.

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Boden, R; Begent, RH; (2001) Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images. Cancer Biother Radiopharm , 16 (5) pp. 391-400. 10.1089/108497801753354294.

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Boden, R; Dearling, J; Bhatia, J; (2001) Effectiveness of radiolabelled antibodies for radio-immunotherapy in a colorectal xenograft model: A comparative study using the linear-quadratic formulation. International Journal of Radiation Biology , 77 (4) pp. 507-517. 10.1080/09553000010024902.

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Boden, R; Dearling, J; Bhatia, J; (2001) Effectiveness of radiolabelled antibodies for radio-immunotherapy in a colorectal xenograft model: a comparative study using the linear-quadratic formulation. INT J RADIAT BIOL , 77 (4) 507 - 517.

Furlanetto, A; Colombari, R; Capelli, P; Quaglia, A; Dhillon, AP; (2001) Inflammatory pseudotumor of the liver: A morphological and immunohistochemical study of 10 cases. J HEPATOL , 34 230 - 230.

G

Gambus, G; Bourboulia, D; Esteve, A; Lahoz, R; Rodriguez, C; Bolao, F; Sirera, G; ... Casabona, J; + view all (2001) Prevalence and distribution of HHV-8 in different subpopulations, with and without HIV infection, in Spain. AIDS , 15 (9) 1167 - 1174.

Gary, J; (2001) Thalidomide brilliant at beating Lung Cancer. The Mirror 24-.

Gerrard, G; Ganeshaguru, K; Baker, R; Potter, M; Prentice, HG; Burgess, M; Herbert, L; ... Mehta, AB; + view all (2001) A Phase 1 study of a P-gP inhibitor Zosuquidar (LY 335979), given by short intravenous infusion in combination with daunorubicin and cytarabine in AML/MDS patients. In: (pp. 177B-177B). AMER SOC HEMATOLOGY

Giannikaki, ES; Colombari, R; Dhillon, AP; (2001) Achieving accuracy in the diagnosis of disease. Defining the utility of biopsy, staging/grading and current issues in the interpretation of results. In: Dusheiko, G and Rosenberg, W and Miles, A, (eds.) The effective management of hepatitis C infection. (pp. 65-72). Aesculapius Medical Press: London.

Glassford, J; Holman, M; Banerji, L; Clayton, E; Klaus, GG; Turner, M; Lam, EW; (2001) Vav is required for cyclin D2 induction and proliferation of mouse B lymphocytes activated via the antigen Receptor. Journal of Biological Chemistry , 276 (44) pp. 41040-41048. Gold open access

Goodchild, K; Hill, SA; Sibtain, A; Chaplin, DJ; Makris, A; (2001) Assessment of microregional blood flow in human breast carcinomas after administration of anthracycline chemotherapy. British Journal of Cancer , 85 p. 48.

Green, AJ; Baig, S; Begent, RHJ; (2001) Use of gadolinium-153 transmission attenuation maps for quantitative I-131SPECT with dual window scatter correction. European Journal of Nuclear Medicine , 28 (8) S131-.

Green, AJ; Baig, S; Francis, RJ; Begent, RHJ; (2001) Semi quantitative analysis of F18-FDG imaging using a hybrid camera for the assessment of tumour response to therapy. European Journal of Nuclear Medicine , 28 (8) S132-.

Green, AJ; Johnson, CJ; Adamson, KL; Begent, RHJ; (2001) Mathematical model of antibody targeting: important parameters defined using clinical data. Physics in Medicine and Biology , 46 (6) pp. 1679-1693.

Green, AJ; Johnson, CJ; Adamson, KL; Begent, RHJ; (2001) Mathematical model of antibody targeting: important parameters defined using clinical data. PHYS MED BIOL , 46 (6) 1679 - 1693.

Gricks, CS; Rawlings, E; Foroni, L; Madrigal, JA; Amlot, PA; (2001) Somatically mutated regions of immunoglobulin on human B cell lymphomas code for peptides that bind to autologous MHC Class I providing a potential target for cytotoxic T cells. Cancer Research , 61 (13) pp. 5145-5152.

Gricks, CS; Rawlings, E; Foroni, L; Madrigal, JA; Amlot, PL; (2001) Somatically mutated regions of immunoglobulin on human B-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells. CANCER RES , 61 (13) pp. 5145-5152.

Gricks, CS; Rawlings, E; Foroni, L; Madrigal, JA; Amlot, PL; (2001) Somatically mutated regions of immunoglobulin on human B-cell lymphomas code for peptides that bind to autologous major histocompatibility complex class I, providing a potential target for cytotoxic T cells. Cancer Research , 61 (13) pp. 5145-5152.

Guiducci, C; Cerone, MA; Bacchetti, S; (2001) Expression of mutant telomerase in immortal telomerase-negative human cells results in cell cycle deregulation, nuclear and chromosomal abnormalities and rapid loss of viability. Oncogene , 20 (6) pp. 714-725. 10.1038/sj.onc.1204145.

H

Hackshaw, AK; Wald, NJ; George, LM; (2001) Measuring serum markers once or twice in each assay in antenatal screening for Down syndrome and neural tube defects. PRENATAL DIAG , 21 (1) 72 - 72.

Hackshaw, AK; Wald, NJ; George, LM; (2001) Singleton versus duplicate assays in maternal serum screening - Reply. PRENATAL DIAG , 21 (10) 895 - 896.

Hadjur, S; Ung, K; Wadsworth, LD; Dimmick, J; Scott, RW; Buchwald, M; Jirik, FR; (2001) Defective hematopoiesis and hepatic steatosis in mice with combined deficiencies of the genes encoding Fancc and Cu/Zn superoxide dismutase. BLOOD , 98 (11) 69A - 69A.

Hames, RS; Wattam, SL; Yamano, H; Bacchieri, R; Fry, AM; (2001) APC/C-mediated destruction of the centrosomal kinase Nek2A occurs in early mitosis and depends upon a cyclin A-type D-box. EMBO J. , 20 (24) pp. 7117-7127.

Hancock, BW; Gregory, WM; Cullen, MH; Hudson, GV; Burton, A; Selby, P; Maclennan, KA; ... British Natl Lymphoma Investigatio, ; + view all (2001) ChlVPP alternating with PABIOE is superior to PABIOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial. BRIT J CANCER , 84 (10) 1293 - 1300. 10.1054/bjoc.2001.1778.

Hardy, SJ; Shah, SK; Pizzey, A; Khwaja, A; Yong, KL; (2001) Monocytes rescue endothelial cells from apoptosis: Role of nuclear factor kappa B (NF-kappa B). BLOOD , 98 (11) 16A - 16A.

Hartley, JA; (2001) Alkylating agents. In: Souhami, RL and Tannock, IF and Hohenberger, P and Horiot, JC, (eds.) Oxford Textbook of Oncology. (pp. 639-654).

Hennessy, BJ; Orchard, KH; Potter, MN; (2001) Novel approaches to transplant conditioning. HEMATOL ONCOL , 19 (2) 43 - 57.

Hercus, B; Revell, PA; (2001) Phenotypic characteristics of T lymphocytes in the interfacial tissue of aseptically loosened prosthetic joints. Journal of Materials Science: Materials in Medicine , 12 (10-12) pp. 1063-1067.

Horton, MA; Seligsohn, U; Massey, HM; Flanagan, AM; (2001) Upregulation of alpha 2 beta 1 integrin in beta 3 null type Glanzmann Thrombasthenia enables bone resorption. JOURNAL OF BONE AND MINERAL RESEARCH , 16 S154-S154.

Hoskin, PJ; Chow, EL; Wu, J; Coia, L; (2001) Uncertainties in the measurement of metastatic bone pain. In: (pp. S5-).

Hoskin, PJ; Dickson, J; (2001) Clincal uncertainties in the use of radical nodal irradiation in Hodgkins disease. In: (pp. S3-).

Hoskin, PJ; Dickson, J; (2001) Survival and morbidity after post operative vaginal va. In: (pp. 90-).

Hoskin, PJ; Yarnold, JR; Roos, DR; Bentzen, S; (2001) Radiotherapy for bone metastases. Clinical Oncology , 13 (2) pp. 88-90.

Howie, AJ; Ferreira, MAS; Adu, D; (2001) Prognostic value of simple measurement of chronic damage in renal biopsy specimens. Nephrology Dialysis Transplantation , 16 (6) pp. 1163-1169.

Huntly, BJP; Bench, AJ; Reid, AG; Nacheva, EP; Byrne, J; Brizzard, A; Niederweiser, D; ... Green, AR; + view all (2001) Lack of expression of the ABL-BCR transcript is not always associated with deletion of the derivative chromosome 9 and does not explain the poor prognosis associated with these deletions in CML. BLOOD , 98 (11) 260B - 260B.

I

ITN, NLSIBRB; (2001) Thalidomide: new use for drug. UNSPECIFIED

J

Jacqui Thornton, MR; (2001) Can the drug which did this cure cancer? Thalidomide shrinks tumours. The Sun 39-.

James, M; (2001) Thalidomide may fight cancer. Independent

James, M; (2001) Thalidomide may fight cancer. Tablets that caused horrific birth defects thought to help shrink tumours. The Guardian 2-.

Jansen, S; Pearson, T; Morgan, NV; Tipping, AJ; Kuyt, LP; Mathew, CG; (2001) The genealogy of Fanconi Anaemia patients homozygotic for the type I and type II Afrikaner mutations. AM J HUM GENET , 69 (4) 397 - 397.

Javed, MS; Harrison, E; Gillams, A; Amin, A; Ledermann, J; Lees, W; Taylor, I; (2001) The multimodal treatment of colorectal liver metastases. In: BRIT J SURG. (pp. 68 - 68). BLACKWELL SCIENCE LTD

Jennings, SA; Toth, JL; Roller, SG; Brooks, N; O'Hare, C; Kiakos, K; Hartley, JA; ... Lee, M; + view all (2001) Efficient synthesis of (+/-)-seco-cyclopropaneindoline analogs of CC-1065. HETEROCYCL COMMUN , 7 (1) 7 - 16.

Jenny, H; (2001) Thalidomide therapy. Disgraced drug offers hope in lung cancer fight. Daily Mail 39-.

Jeremy, L; (2001) Thalidomide is used to treat lung cancer. The Independent

Jo, H; (2001) Thalidomide hope for Cancer. GP Magazine 33-.

John, C; (2001) Thalidomide for cancer victims. Daily Express

Joshi, CV; Gale, KB; Thykjaer, TA; Orntoft, T; Enver, T; (2001) GATA-2-dependent modulation of transcriptional profiles in hematopoietic progenitor cells. BLOOD , 98 (11) 551A-552A.

K

Kenny, PA; Danielian, PS; Dale, TC; Enver, T; Ashworth, A; (2001) Identification of novel Wnt-1/beta-catenin target genes in mouse mammary epithelial cells. MOLECULAR BIOLOGY OF THE CELL , 12 100A-100A.

Kiakos, K; Brooks, N; Hartley, JA; Toth, J; Lee, M; (2001) Design, synthesis,cytotoxicity and sequence specificity of N-methylpyrrole C-and N-terminus linked seco-cyclopropylindole hybrid molecules. In: (pp. 1374-).

Kiakos, K; Brooks, N; McHugh, PJ; Loward, T; Lee, M; Hartley, JA; (2001) Repair of seqence specific adenine-N3 alkylations in the minor groove of DNA. In: (pp. 3737-).

Kocjan, G; (2001) Clinical Cytopathology of the Head and Neck: a Text and Atlas. [Book]. (1 vols). (1 ed.). Greenwich Medical Media, now Cambridge University Press: London.

Kocjan, G; Miller, R; (2001) The cytology of HIV-induced immunosuppression. Changing pattern of disease in the era of highly active antiretroviral therapy. CYTOPATHOLOGY , 12 (5) 281 - 296.

Kottaridis, PD; Gale, RE; Langabeer, SE; Linch, DC; (2001) Changes in the pattern of FLT3 mutations between diagnosis and relapse restricts their potential use as markers of minimal residual disease in patients with acute myeloid leukaemia. BLOOD , 98 (11) 717A - 718A.

L

LEDERMANN, J; (2001) Relapse with ascites within 12 months of diagnosis. In: Ledermann, JA and Hoskins, WJ and Kaye, SB, (eds.) Clinical management of ovarian cancer. (pp. 147-158). Informa HealthCare: London UK.

Lader, CS; Scopes, J; Horton, MA; Flanagan, AM; (2001) Generation of human osteoclasts in stromal cell-free and stromal cell-rich cultures: differences in osteoclast CD11c/CD18 integrin expression. BRIT J HAEMATOL , 112 (2) 430 - 437.

Langabeer, SE; Rogers, JR; Harrison, G; Wheatley, K; Walker, H; Bain, BJ; Burnett, AK; ... MRC Adult Leukaemia Working Part, ; + view all (2001) EVI1 expression in acute myeloid leukaemia. BRIT J HAEMATOL , 112 (1) 208 - 211.

Lawrie, AS; Mackie, IJ; Purdy, G; Machin, SJ; (2001) Effect of lupus anticoagulants on INR with different thromboplastins. BLOOD COAGUL FIBRIN , 12 (3) 221 - 221.

Ledermann, JA; Leonard, P; Seymour, M; (2001) Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer. NEW ENGL J MED , 345 (2) 145 - 146.

Levine, TS; Rolfe, KJ; Crow, J; Styles, S; Perrett, CW; MacLean, AB; Reid, WMN; (2001) The use of cytospin monolayer technique in the cytological diagnosis of vulval and anal disease. CYTOPATHOLOGY , 12 (5) 297 - 305.

Liatsos, C; Mehta, AB; Potter, M; Burroughs, AK; (2001) The hepatologist in the haematologists' camp. Br J Haematol , 113 (3) pp. 567-578.

Little, AM; Cox, ST; Hoddinott, MA; Ogilvie, H; Bohan, EM; Mufti, GJ; Madrigal, JA; (2001) Identification of HLA-B*0722. Tissue Antigens , 57 (2) pp. 167-168.

Little, AM; Cox, ST; Hoddinott, MA; Ogilvie, H; Bohan, EM; Mufti, GJ; Madrigal, JA; (2001) Identification of HLA-B*0722. Tissue Antigens , 57 (2) pp. 167-168.

Love, EM; Jones, H; Williamson, EM; Cohen, H; (2001) The 1999/2000 annual SHOT report (on behalf of the serious hazards of transfusion steering group).

Lowdell, MW; (2001) Allogeneic immunotherapy of acute leukaemia. CME Bulletin Haematology , 3 (3) pp. 63-66.

Lowdell, MW; (2001) Data analysis in flow cytometry. In: McCarthy, D and Macey, MG, (eds.) Cytometric Analysis of Cell Phenotype and Function. Cambridge University Press: Cambridge.

Lowdell, MW; Lamb, L; Hoyle, C; Velardi, A; Prentice, HG; (2001) Non-MHC-restricted cytotoxic cells: Their roles in the control and treatment of leukaemias. BRIT J HAEMATOL , 114 (1) 11 - 24.

Luzzatto, L; Mehta, AB; Vulliamy, T; (2001) Glucose-6-phosphate Dehydrogenase Deficiency. Metabolic and Molecular Basics of Inherited Disease. In: Scriver, CR and Beaudet, AL and Sly, WS and Valle, D, (eds.) The Metabolic & Molecular Bases of Inherited Diseases. (pp. 4517-4554).

M

Mackie, IJ; Piegsa, K; Furs, SA; Johnson, J; Bounds, W; Machin, SJ; Guillebaud, J; (2001) Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-over. BRIT J HAEMATOL , 113 (4) 898 - 904.

Mainwaring, P.N.; Cunningham, D.; Gregory, W.; Hoskin, P.; Hancock, B.; Norton, A.J.; MacLennan, K.; ... Linch, D.; + view all (2001) Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO. Blood , 97 (10) pp. 2991-2997. 10.1182/blood.V97.10.2991. Green open access
file

Mainwaring, PN; Cunningham, D; Gregory, W; Hoskin, P; Hancock, B; Norton, AJ; MacLennan, K; ... Linch, D; + view all (2001) Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO. Blood , 15 (97) pp. 2991-2997.

Mainwaring, PN; Cunningham, D; Gregory, W; Hoskin, P; Hancock, B; Norton, AJ; MacLennan, K; ... Linch, D; + view all (2001) Mitoxantrone is superior to doxorubicin in a multiagent weekly regimen for patients older than 60 with high-grade lymphoma: results of a BNLI randomized trial of PAdriaCEBO versus PMitCEBO. Blood , 97 (10) pp. 2991-2997.

Makris, A; Burcombe, RJ; Cladd, H; Smith, JM; Makris, M; (2001) Raised plasma homocysteine levels in women with metastatic breast cancer. British Journal of Cancer , 85 p. 26.

Mallett, SV; Peachey, TD; Sanehi, O; Hazelhurst, G; Mehta, A; (2001) A reducing red blood cell transfusion in elective surgical patients: the role of audit and practice guidelines. Anaesthesia , 55 pp. 1003-1024.

Marsh, SG; (2001) Nomenclature for factors of the HLA System, update February 2001. Eur J Immunogenet , 28 (4) pp. 463-464.

Marsh, SG; (2001) Nomenclature for factors of the HLA System, update March 2001. Eur J Immunogenet , 28 (4) 465-.

Marsh, SG; (2001) Nomenclature for factors of the HLA system, update December 2000. Tissue Antigens , 57 (2) pp. 180-183.

Marsh, SG; (2001) Nomenclature for factors of the HLA system, update January 2001. Tissue Antigens , 57 (4) pp. 394-395.

Marsh, SG; (2001) Nomenclature for factors of the HLA system, update November 2000. Tissue Antigens , 57 (2) pp. 177-179.

Marsh, SG; Bodmer, JG; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; ... Terasaki, PI; + view all (2001) Nomenclature for factors of the HLA system, 2000. Hum Immunol , 62 (4) pp. 419-468.

Marsh, SG; Bodmer, JG; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; ... Terasaki, PI; + view all (2001) Nomenclature for factors of the HLA system, 2000. Tissue Antigens , 57 (3) pp. 236-283.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update April 2001. Tissue Antigens , 58 (3) pp. 207-208.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update February 2001. Tissue Antigens , 57 (6) pp. 551-552.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update July 2001. Tissue Antigens , 58 (4) pp. 278-279.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update June 2001. Hum Immunol , 62 (10) pp. 1187-1188.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update June 2001. Tissue Antigens , 58 (4) pp. 276-277.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update March 2001. Tissue Antigens , 57 (6) pp. 553-554.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update May 2001. Hum Immunol , 62 (10) pp. 1185-1186.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update May 2001. Tissue Antigens , 58 (3) pp. 209-210.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2001) Nomenclature for factors of the HLA system, update October 2000. Tissue Antigens , 57 (1) pp. 93-94.

Marsh, SG; WHO Nomenclature Committee for factors of the HLA system, ; (2001) Nomenclature for factors of the HLA system, Update December 2000. Hum Immunol , 62 (3) pp. 294-296.

Marsh, SG; WHO Nomenclature Committee for factors of the HLA system, ; (2001) Nomenclature for factors of the HLA system, Update November 2000. Hum Immunol , 62 (3) pp. 292-293.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update April 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (5) p. 557. 10.1046/j.1365-2370.2001.00295.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update August 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (1) pp. 101-102. 10.1046/j.1365-2370.2001.00255.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update August 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (6) pp. 599-600. 10.1046/j.1365-2370.2001.00306.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update December 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (2) pp. 191-193.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update January 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (3) pp. 439-440. 10.1046/j.1365-2370.2001.00278.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update July 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (6) p. 597. 10.1046/j.1365-2370.2001.00298.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update June 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (5) p. 561. 10.1046/j.1365-2370.2001.00297.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update May 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (5) p. 559. 10.1046/j.1365-2370.2001.00296.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update November 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (2) pp. 189-190.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update October 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (2) pp. 187-188. 10.1046/j.1365-2370.2001.00257.x.

Marsh, SGE; (2001) Nomenclature for factors of the HLA System, update September 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (1) p. 103. 10.1046/j.1365-2370.2001.00256.x.

Marsh, SGE; Bodmer, JG; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, S; Erlich, HA; ... Terasaki, PI; + view all (2001) Nomenclature for factors of the HLA system, 2000. EUROPEAN JOURNAL OF IMMUNOGENETICS , 28 (3) pp. 377-424. 10.1046/j.1365-2370.2001.00268.x.

Massey, HM; Scopes, J; Horton, MA; Flanagan, AM; (2001) Transforming growth factor-beta 1 (TGF-beta) stimulates the osteoclast-forming potential of peripheral blood hematopoietic precursors in a lymphocyte-rich microenvironment. BONE , 28 (6) 577 - 582.

Massey, HM; Steward, CG; Wilson, C; Vellodi, A; Horton, MA; Flanagan, AM; (2001) Recombinant human RANK ligand (RANKL) and macrophage colony-stimulating factor (M-CSF) fail to rescue human infantile osteoclast-poor osteopetrosis (OP) in vitro. BONE , 28 (5) S114 - S114.

McCloskey, KE; Zborowski, M; Chalmers, JJ; (2001) Measurement of CD2 expression levels of IFN-alpha-treated fibrosarcomas using cell tracking velocimetry. Cytometry , 44 (2) pp. 137-147.

McHugh, PJ; Spanswick, VJ; Hartley, JA; (2001) Repair of DNA interstrand crosslinks molecular mechanisms and clinical relevance. The Lancet Oncology , 2 pp. 483-490.

Mehta, A; Guidelines, C; (2001) Diagnosis and management of myeloma. British Journal of Haematology , 115 pp. 522-540.

Mehta, AB; (2001) Anaemia. In: Bloom, SL, (ed.) Practical Gastroenterology. (pp. 321-330). Martin Dunitz Ltd

Mehta, AB; Burroughs, AK; (2001) Thrombopoietin concentration after orthotopic liver transplantation. British Journal of Haematology , 114 (4) pp. 960-961.

Mehta, AB; Hennessy, B; (2001) Gastrointestinal problems in haematological patients. In: Bloom, SL, (ed.) Practical Gastroenterology. (pp. 55-70). Martin Dunitz Ltd

Mehta, ABBAK; (2001) Thrombopoietin concentration after orthotopic liver. British Journal of Haematology , 114 (4) pp. 960-961.

Meyer, T; Cole, LA; Richman, PI; Mitchell, HD; Myers, J; Rustin, GJ; (2001) High levels of hCG in choriocarcinoma can result in renal failure and a false-negative pregnancy test in men. Clin Oncol (R Coll Radiol) , 13 (4) pp. 301-303.

Meyer, T; Davidson, B; Hochhauser, D; Dhillon, P; Begent, R; (2001) Fibrolamellar Carcinoma: a Strategy for Management. In: (Proceedings) ASCO General Meeting. (pp. 2311-).

Miles, DW; Smith, IE; Coleman, RE; Calvert, AH; Lind, MJ; (2001) A phase II study of pemetrexed disodium (LY231514) in patients with locally recurrent or metastatic breast cancer. EUR J CANCER , 37 (11) 1366 - 1371.

Milton, NG; Mayor, NP; Rawlinson, J; (2001) Identification of amyloid-beta binding sites using an antisense peptide approach. Neuroreport , 12 (11) pp. 2561-2566.

Mollapour, E; Linch, DC; Roberts, PJ; (2001) Activation and priming of neutrophil nicotinamide adenine dinucleotide phosphate oxidase and phospholipase A(2) are dissociated by inhibitors of the kinases p42(ERK2) and p38(SAPK) and by methyl arachidonyl fluorophosphonate, the dual inhibitor of cytosol. Blood , 97 (8) pp. 2469-2477.

Moreira, I; Papaionnou, M; Mortuza, FY; Gameiro, P; Palmisano, GL; Swanton, S; Harrison, CJ; ... Foroni, L; + view all (2001) Oligoclonality: an insight into the biology of acute lymphoblastic leukaemia. Leukemia , 15 (10) pp. 1527-1533.

Mortuza, FY; Moreira, IM; Papaioannou, M; Gameiro, P; Coyle, LA; Gricks, CS; Amlot, P; ... Foroni, L; + view all (2001) Immunoglobulin heavy-chain gene rearrangement in adult acute lymphoblastic leukemia reveals preferential usage of J(H)-proximal variable gene segments. BLOOD , 97 (9) pp. 2716-2726. 10.1182/blood.V97.9.2716.

Mulatero, CW; Penson, RT; Papamichael, D; Gower, NH; Evans, MT; Rudd, RM; (2001) 'A phase II study of combined intravenous and subcutaneous interleukin-2 in malignant pleural mesothelioma'. Lung Cancer , 31 pp. 67-72.

Murphy, MF; Wallington, TB; Kelsey, P; Boulton, F; Bruce, M; Cohen, H; Duguid, J; ... British Committee for Standards in Haematology, BTTF; + view all (2001) Guidelines for the clinical use of red cell transfusions. British journal of haematology , 113 pp. 24-31.

N

Nathan, PD; Walker, D; Bridle, H; Ross, A; Stevenson, A; Lee, SM; Eisen, TG; (2001) A phase II study investigating the use of thalidomide in conjunction with interferon-alpha in patients with metastatic renal cell carcinoma. In: (Proceedings) 2001 ASCO Annual Meeting/37th Annual Meeting, San Francisco, California.. (pp. 265a-). Proceedings of the American Society of Clinical Oncology

Nathwani, AC; Davidoff, A; Hanawa, H; Zhou, JF; Vanin, EF; Nienhuis, AW; (2001) Factors influencing in vivo transduction by recombinant adeno-associated viral vectors expressing the human factor IX cDNA. Blood , 97 (5) pp. 1258-1265. Green open access
file

Ndisang, D; Budhram-Mahadeo, V; Pedley, RBAL; D, S; (2001) The Brn-3a transcription factor plays a key role in regulating the growth of cervical cells in vivo. Oncogene , 20 pp. 4899-4903.

New, HV; Harrison, CN; Rodeck, CH; de Silva, M; Cohen, H; (2001) Antenatal antibody screening. LANCET , 357 (9264) 1295 - 1295.

Nigel, H; (2001) Thalidomide returns in lung cancer battle. The Times 12-.

Nikitenko, LL; Brown, NS; Smith, DM; MacKenzie, IZ; Bicknell, R; Rees, MCP; (2001) Differential and cell-specific expression of calcitonin receptor-like receptor and receptor activity modifying proteins in the human uterus. MOL HUM REPROD , 7 (7) 655 - 664.

Nutting, C; Short, S; (2001) Where now with training in clinical oncology? Clinical Oncology , 13 pp. 4-5.

O

O'Nions, J; Brooks, LA; Sullivan, A; Bell, A; Dunne, B; Rozycka, M; Reddy, A; ... Crook, T; + view all (2001) p73 is over-expressed in vulval cancer principally as the Delta 2 isoform. Br J Cancer , 85 (10) pp. 1551-1556. 10.1054/bjoc.2001.2138.

Osborne, M; Makris, A; Hoskin, PJ; Lowe, J; Emmott, J; Wong, WL; (2001) The role of FDG whole body positron emission tomography in metastatic carcinoma of unknown primary site. British Journal of Cancer , 85 p. 90.

Osborne, M; Shah, N; Hoskin, PJ; Powell, MG; Anthony-Pillau, R; Glynne-Jones, R; Makris, A; (2001) Low dose folinic acid with infusional and bolus 5fluorouracil in advanced colorectal carcinoma. British Journal of Cancer , 85 p. 44.

Osborne, ME; Brown, RSD; Hoskin, PJ; (2001) Interaction of bisphosphonates with calcitonin in monitoring medullary carcinoma of the thyroid. Clinical Oncology , 13 (5) pp. 370-371.

P

Parkinson, MC; Harland, SJ; Harnden, P; Sandison, A; (2001) The role of the histopathologist in the management of testicular germ cell tumour in adults. HISTOPATHOLOGY , 38 (3) 183 - 194.

Pay, AL; Little, AM; Madrigal, JA; (2001) Donor selection in allogeneic bone marrow transplantation. In: Carella, AG and Daley, GQ and Eaves, CJ and Goldman, JM and Hehlmann, R, (eds.) Chronic Myeloid Leukaemia Biology and Treatment. (pp. 421-250). Martin Dunitz Ltd: London.

Pay, AL; Little, AM; Madrigal, JA; (2001) Donor selection in allogeneic bone marrow transplantation. In: Carella, AG and Daley, GQ and Eaves, CJ and Goldman, JM and Hehlmann, R, (eds.) Chronic Myeloid Leukaemia Biology and Treatment. (pp. 421-250). Martin Dunitz Ltd: London.

Pedley, R.B.; Hill, S.A.; Boxer, G.M.; Flynn, A.A.; Boden, R.; Watson, R.; Dearling, J.; ... Begent, R.H.; + view all (2001) Eradication of colorectal xenografts by combined radioimmunotherapy and combretastatin A-4 3-O-phosphate. Cancer Research , 61 (12) pp. 4716-4722.

Pedley, RB; Flynn, AA; Dearling, J; Watson, R; Boxer, G; Boden, R; Hill, SA; ... Begent, RHJ; + view all (2001) Overcoming the problem of tumour heterogeneity by combined, regios-specific therapies. In: (pp. 871-).

Pedley, RB; Flynn, AA; Dearling, J; Watson, R; Boxer, GM; Boden, R; Hill, SA; ... and Begent, RHJ; + view all (2001) Overcoming the problem of tumour heterogeneity by combined, region-specific therapies. In: (Proceedings) Proceedings American Association for Cancer Research. (pp. 871-).

Pickard, DCO; Bigio, IJ; Bown, SG; Lovat, LB; Ripley, PM; Novelli, M; (2001) Optical biopsy for the diagnosis of dysplasia in Barrett's oesophagus. In: (Proceedings) SPIE - The International Society for Optical Engineering. (pp. pp. 179-185).

Pickard, DCO; Bigio, IJ; Bown, SG; Lovat, LB; Ripley, PM; Novelli, M; (2001) Optical biopsy for the diagnosis of dysplasia in Barrett's oesophagus. In: Papazoglou, TG and Wagnieres, GA, (eds.) UNSPECIFIED (179 - 185). SPIE-INT SOC OPTICAL ENGINEERING

Porakishvili, N; Roschupkina, T; Kalber, T; Jewell, AP; Patterson, K; Yong, K; Lydyard, PM; (2001) Expansion of CD4<sup>+</sup>T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL). Clinical and Experimental Immunology , 126 (1) pp. 29-36. 10.1046/j.1365-2249.2001.01639.x.

Pritchard, JK; Devine, T; Lewis, I; Whelan, J; Hale, J; Campbell, B; Pagonis, C; (2001) Endogenous and induced immune responses to the 105AD7 anti-idiotypic vaccine in osteosarcoma patients following intensive chemotherapy. In:

Puar, U; Wickremasinghe, RG; Prentice, HG; Hoffbrand, AV; Mehta, AB; Ganeshaguru, K; (2001) Inhibitor of apoptosis XIAP expression in cells from B-CLL patients treated with DNA damaging agents. BLOOD , 98 (11) 181B - 182B.

Q

Quaglia, A; Dhillon, A; Colombari, R; Togni, R; Dalla Palma, P; Michelis, E; Bioulac-Sage, P; ... Dhillon, AP; + view all (2001) A novel scoring sytem for the histological diagnosis of hepatocellular carcinoma in cirrhotic liver. J HEPATOL , 34 105 - 105.

Quarmby, JW; Engelke, C; Chitolie, A; Morgan, RA; Belli, AM; (2001) Autologous thrombin-induced thrombosis of pseudoaneurysms. BRIT J SURG , 88 (4) 616 - 616.

R

Reid, A; Gribble, SM; Andrews, KM; Green, AR; Nacheva, EP; (2001) Chromosome band specific FISH probes allow improved detection of terminal translocations in leukaemic metaphases. In: LEUKEMIA. (pp. 860 - 861). NATURE PUBLISHING GROUP

Reid, AG; Huntly, BJP; Campbell, L; Telford, N; Bown, N; Grace, CD; Green, AR; (2001) Extensive deletion at the t(9;22) break-point occurs in a minority of patients with Philadelphia-positive acute lymphoblastic leukaemia. BLOOD , 98 (11) 316A - 316A.

Reynard, MP; Turner, D; Lowdell, M; Navarrete, CV; (2001) Cytokine gene polymorphisms associated with outcome of bone marrow transplantation. European Journal of Immunogenetics , 28 (2) 241-.

Robinson, J; Perez-Rodriguez, M; Waller, MJ; Cuillerier, B; Bahram, S; Yao, Z; Albert, ED; ... Marsh, SGE; + view all (2001) MICA sequences 2000. IMMUNOGENETICS , 53 (2) pp. 150-169. 10.1007/s002510100303.

Robinson, M; Machin, S; Mackie, I; Harrison, P; (2001) Comparison of glycocalicin, thrombopoietin and reticulated platelet measurement as markers of platelet turnover in HIV plus samples. PLATELETS , 12 (2) 108 - 113.

Rodriguez-Justo, M; Fisher, T; Wotherspoon, AC; (2001) Hodgkin's disease with an intrasinusoidal pattern of infiltration. A report of two cases. Virchows Arch , 439 (5) pp. 691-696.

Rodríguez-Justo, M; Aramburu-González, JA; Santonja, C; (2001) Glomangiosarcoma of abdominal wall. Virchows Arch , 438 (4) pp. 418-420.

Rosette, C; Werlen, G; Daniels, MA; Holman, PO; Alam, SM; Travers, PJ; Gascoigne, NRJ; ... Jameson, SC; + view all (2001) The impact of duration versus extent of TCR occupancy on T cell activation: A revision of the kinetic proofreading model. Immunity , 15 (1) pp. 59-70.

Rubin, E; Mittnacht, S; Villa-Moruzzi, E; Ludlow, JW; (2001) Site-specific and temporally-regulated retinoblastoma protein dephosphorylation by protein phosphatase type 1. ONCOGENE , 20 (29) pp. 3776-3785. 10.1038/sj.onc.1204518.

S

Samuels-Lev, Y; O'Connor, DJ; Bergamaschi, D; Trigiante, G; Hsieh, JK; Zhong, S; Campargue, I; ... Lu, X; + view all (2001) ASPP proteins specifically stimulate the apoptotic function of p53. Molecular Cell , 8 (4) pp. 781-794.

Sargent, DJ; Niedzwiecki, D; O'Connell, MJ; Schilsky, RL; (2001) Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer. N Engl J Med , 345 (2) pp. 144-145. 10.1056/NEJM200107123450213.

Sarukhan, A; Soudais, C; Danos, O; Jooss, K; (2001) Factors influencing cross-presentation of non-self antigens expressed from recombinant adeno-associated virus vectors. J Gene Med , 3 (3) pp. 260-270. 10.1002/jgm.175.

Saunders, MI; (2001) Programming of radiotherapy in the treatment of non-small-cell lung cancer- Away to advance care. The Lancet Oncology , 2 pp. 401-408.

Scaffidi, P; Bianchi, ME; (2001) Spatially Precise DNA Bending Is an Essential Activity of the Sox2 Transcription Factor. Journal of Biological Chemistry , 276 (50) pp. 47296-47302. 10.1074/jbc.M107619200.

Scheimberg, I; Bates, AW; Lee, A; (2001) Getting consent for necropsies - Most relatives give consent once reasons for necropsy are explained. BRIT MED J , 323 (7326) 1426 - 1426.

Schreuder, GMTH; Hurley, CK; Marsh, SGE; Lau, M; Maiers, M; Killman, C; Noreen, HJ; (2001) The HLA dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-, -B, -C, -DR and -DQ antigens. Human Immunology , 62 pp. 826-849.

Schreuder, GMTH; Hurley, CK; Marsh, SGE; Lau, M; Maiers, M; Killman, C; Noreen, HJ; (2001) The HLA dictionary 2001: a summary of HLA-A, -B, -C, DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. European Journal of Immunogenetics , 28 pp. 565-596.

Schreuder, GMTH; Hurley, CK; Marsh, SGE; Lau, M; Maiers, M; Killman, C; Noreen, HJ; (2001) The HLA dictitionary 2001: a summar of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR antigens. Tissue Antigens , 58 pp. 109-140.

Scopes, J; Massey, HM; Ebrahim, H; Horton, MA; Flanagan, AM; (2001) Interleukin-4 and interleukin-13: Bidirectional effects on human osteoclast formation. BONE , 29 (3) 203 - 208.

Sebire, NJ; Flanagan, AM; Goldin, RD; (2001) Osseous metaplasia in fetal mesenchyme of the human placenta. In: J PATHOL. (pp. 18A - 18A). JOHN WILEY & SONS LTD

Shah, N; Joiner, MC; Saunders, MI; (2001) An evaluation of human skin epidermal cells for hyper- radiosensitivity. British Journal of Cancer , 85 p. 16.

Sharma, SK; Bhatia, J; Pedley, RB; Spencer, DIR; Minton, N; Chester, KA; Begent, RHJ; (2001) Immunogenicity of carboxypeptidase G2 (CPG2) enzyme in ADEPT. BRIT J CANCER , 85 98 - 98.

Sharma, SK; Bhatia, J; Pedley, RB; Spencer, DIR; Minton, N; Chester, KA; Begent, RHJ; (2001) Immunogenicity of carboxypeptidase G2 (CPG2) enzyme in ADEPT. In: (pp. p. 98).

Sharma, SK; Bhatia, J; Pedley, RB; Spencer, DIR; Minton, N; Chester, KAAB; R, HJ; (2001) Immunogenicity of carboxypeptidase G2(CPG2) enzyme in ADEPT. In: (Proceedings) Proceedings BACR, Br J Cancer. (pp. 98-).

Sharma, SK; Irwin, H; Pedley, RB; Bhatia, J; Dearling, J; Flynn, A; Chester, KA; (2001) Biodistribution of I-123-labelled MFE-CP fusion protein in LS174T xenografted nude mice. British Journal of Cancer , 85 p. 99.

Sharma, SK; Irwin, H; Pedley, RB; Bhatia, J; Dearling, J; Flynn, A; Chester, KA; (2001) Biodistribution of I-123-labelled MFE-CP fusion protein in LS174T xenografted nude mice. BRIT J CANCER , 85 99 - 99.

Sharma, SK; Pedley, RB; Bhatia, J; Boxer, GM; Minton, N; Chester, KA; Begent, RHJ; (2001) Optimising antibody-directed enzyme prodrug therapy (ADEPT) in human colon cancer xenografts. In: (pp. 136-).

Sharma, SK; Pedley, RB; Bhatia, J; Boxer, GM; Minton, N; Chester, KAAB; R, HJ; (2001) Optimising antibody-directed enzyme prodrug therapy (ADEPT) in human colon cancer xenografts. In: (Proceedings) Proceedings American Association for Cancer Research. (pp. 136-).

Shaw, BE; Madrigal, JA; Potter, M; (2001) Improving the outcome of unrelated donor stem cell transplantation by molecular matching. BLOOD REV , 15 pp. 167-174.

Shaw, BE; Pay, AL; Mayor, N; Potter, MN; Prentice, GH; Goldman, JM; Robinson, J; ... Madrigal, AJ; + view all (2001) High resolution molecular typing to ensure allele level matching for six highly polymorphic HLA antigens increases the overall survival in volunteer donor stem cell transplantation, however 'perfect' matches are found in only 10% of pairs. BLOOD , 98 (11) 668A - 668A.

Shaw, BE; Perry, D; Hoffbrand, AV; (2001) Progressive arterial thrombosis in a patient with non-Hodgkin's lymphoma, a lupus anticoagulant, factor V Leiden mutation and paraprotein, following chemotherapy. LEUKEMIA LYMPHOMA , 42 (1-2) 221 - 223.

Short, S; (2001) Thalidomide as an anti-angiogenic agent in recurrent gliomas. Journal of Neuro-Oncology , 51 pp. 41-55.

Short, SC; Brada, M; (2001) The treatment of malignant celebral tumours. Hospital Medicine , 61 (11) pp. 772-777.

Short, SC; Kelly, J; mayes, CR; Woodcock, M; Joiner, MC; (2001) Low-dose hypersensitivity after fractionated low-dose irradiation. International journal of radiation biology , 77 (6) pp. 655-664.

Short, SC; Traish, D; Dowe, A; Hines, F; Gore, M; Brada, M; (2001) Thalidomide as an anti-angiogenic agent in relapsed gliomas. Journal of Neuro-Oncology , 51 (1) pp. 41-45.

Sibtain, A; Wilson, GD; Hoskin, PJ; (2001) Tumour hypoxia and vascularity in lymphoma. British Journal of Cancer , 85 p. 36.

Sky, NRTM; (2001) Thalidomide could be used to treat lung cancer. UNSPECIFIED

Smith, PG; Thomas, HD; Barlow, HC; Griffin, RJ; Golding, BT; Calvert, AH; Newell, DR; (2001) In vitro and in vivo properties of novel nucleoside transport inhibitors with improved pharmacological properties that potentiate antifolate activity. CLIN CANCER RES , 7 (7) 2105 - 2113.

Somervaille, TCP; Linch, DC; Khwaja, A; (2001) Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax. Blood , 98 (5) pp. 1374-1381. 10.1182/blood.V98.5.1374.

Somervaille, TCP; Linch, DC; Khwaja, A; (2001) Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax. BLOOD , 98 (5) 1374 - 1381.

Somervaille, TCP; Linch, DC; Khwaja, A; (2001) p38 MAP kinase regulates both differentiation and apoptosis in primary human erythroid cells. BLOOD , 98 (11) 78A - 79A.

Spanswick, V; Craddock, C; Sekhar, M; Mahendra, P; Shankaranarayana, P; Hochhauser, D; Hartley, J; (2001) Repair of melphalan induced DNA interstrand crosslinks in patients who relapse after autologous stem cell transplantation for multiple myeloma. In: (pp. 3174-).

Starke, R; Drummond, O; MacGregor, I; Biggerstaff, J; Camilleri, R; Gale, R; Lee, CA; ... Harrison, P; + view all (2001) Endothelial cells express and release soluble prion protein. BLOOD , 98 (11) 247A - 248A.

Stavrou, BM; Lawrence, C; Blackburn, GM; Cohen, T; Sheridan, DJ; Flores, NA; (2001) Coronary vasomotor and cardiac electrophysiologic effects of diadenosine polyphosphates and nonhydrolyzable analogs in the guinea pig. J Cardiovasc Pharmacol , 37 (5) pp. 571-584.

Steele, JPC; O'Doherty, CA; Shamash, J; Evans, MT; Gower, NH; Tischkowitz, MD; Rudd, RM; (2001) Phase II trial of liposomal daunorubicin in malignant pleural mesothelioma. Annals of Oncology , 12 (4) pp. 497-499.

Steele, JPC; Shamash, J; Evans, MT; Goonewardene, TI; Nystrom, ML; Gower, NH; Rudd, RM; (2001) Phase II trial of vinorelbine and oxaliplatin ('VO') in malignant pleural mesothelioma. Proceedings of ASCO , 20 1335-.

Stephens, RJ; Gower, NH; Spiro, SG; Rudd, RM; on, BOTBLTSC; (2001) The Big Lung Trial (BLT): a major randomised trial to determine the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Lung Cancer , 29 (Suppl.) 20-.

Sweetenham, JW; Santini, G; Qian, W; Guelfi, M; Schmitz, N; Simnett, S; Nagler, A; ... Goldstone, AH; + view all (2001) High-dose therapy and autologous stem-cell transplantation versus conventional-dose consolidation/maintenance therapy as postremission therapy for adult patients with lymphoblastic lymphoma: results of a randomized trial of the European Group for Blood. Journal of Clinical Oncology , 19 (11) pp. 2927-2936.

Szmania, S; Galloway, A; Bruorton, M; Musk, P; Aubert, G; Arthur, A; Pyle, H; ... Van Rhee, F; + view all (2001) Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers. Blood , 98 (3) pp. 505-512.

Szmania, S; Galloway, A; Bruorton, M; Musk, P; Aubert, G; Arthur, A; Pyle, H; ... Van Rhee, F; + view all (2001) Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers. BLOOD , 98 (3) pp. 505-512.

T

Takimoto, K; Yaguchi, H; Miyakoshi, J; (2001) Extremely low frequency magnetic fields suppress the reduction of germination rate of Arabidopsis thaliana seeds kept in saturated humidity. Biosci Biotechnol Biochem , 65 (11) pp. 2552-2554.

Taylor, F; Cohen, H; Ebrahim, S; (2001) Long term anticoagulation or antiplatelet treatment - Reply. BRIT MED J , 323 (7306) 235 - 236.

Taylor, FC; Cohen, H; Ebrahim, S; (2001) Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation. BRIT MED J , 322 (7282) 321 - 326.

Taylor, I; Gillams, AR; Lees, WR; Ledermann, JA; (2001) Interstitial laser photocoagulation for recurrent colorectal liver metastases. In: Rau, BK, (ed.) PROCEEDINGS OF THE 14TH WORLD CONGRESS OF THE INTERNATIONAL SOCIETY FOR LASER SURGERY AND MEDICINE. (pp. 69 - 74). MEDIMOND S R L

Taylor, NJ; Baddeley, H; Goodchild, KA; Powell, MEB; Thoumine, M; Culver, LA; Stirling, JJ; ... Griffiths, JR; + view all (2001) BOLD MRI of human tumor oxygenation during carbogen breathing. Journal of Magnetic Resonance Imaging , 14 (2) pp. 156-163.

Taylor, RM; Cheeseman, P; Goldblatt, D; Davenport, M; Mieli-Vergani, G; Dhawan, A; Baker, A; (2001) Humoral immune response in children with bilary atresia splenic malformation syndrome. JOURNAL OF HEPATOLOGY , 34 p. 215.

Timothy, AR; Girling, DJ; Saunders, MI; Macbeth, F; Hoskin, PJ; (2001) Radiotherapy for inoperable lung cancer. Clinical Oncology , 13 (2) pp. 86-87.

Todd, R; Boddy, AV; Verrill, M; Sludden, J; Griffin, MJ; Elliott, S; Fishwick, K; ... Calvert, AH; + view all (2001) Phase I and pharmacological study of CT-2103, a poly(L-glutamic acid)-paclitaxel conjugate. Clinical Cancer Research , 7 (11) 115-.

Tolner, B; Greenberg, B; Hartley, J; Hochhauser, D; (2001) Effects of the DNA minor groove binding agent ecteinascidin (ET-743) on the topoisomerase II alpha promoter. Clinical Cancer Research , 7 (11) 703-.

Truran, LN; Austin, SJ; Langabeer, SE; Kottaridis, PD; Linch, DC; Fisher, J; Burnett, AK; (2001) Quantitative bax and FLT3-ITD characterisation improve prognostic stratification in AML patients with intermediate risk cytogenetics. BLOOD , 98 (11) 578A - 578A.

Tsuzuki, S; Ivins, S; Guidez, F; Zelent, A; Enver, T; (2001) PLZF proteins can function as co-repressors of GATA-family transcription factors. BLOOD , 98 (11) 553A - 553A.

U

UCL, N; (2001) Thalidomide to be used in cancer fight. 14-.

UCL, NFP; (2001) 'Thalidomide tested against cancer'.

Ulrich, S; Helmberg, W; Wagner, T; Corell, A; Marsh, SGE; Lanzer, G; (2001) A novel HLA-DRB1 sequence, DRB1*11272. TISSUE ANTIGENS , 57 (2) pp. 175-176. 10.1034/j.1399-0039.2001.057002175.x.

V

Vacca, M; Filippini, F; Budillon, A; Rossi, V; Mercadante, G; Manzati, E; Gualandi, F; ... Hulten, M; + view all (2001) Mutation analysis of the MECP2 gene in British and Italian Rett syndrome females. J MOL MED-JMM , 78 (11) 648 - +.

Vassileva, VT; (2001) Somatic mutations of target genes induced by DNA damage occur in endometrial carcinomas with microsatellite instability. In: (Proceedings) American Association for Cancer Research Annual Meeting.

Venables, K; Winfield, E; Ariad, EGA; Hoskin, PJ; (2001) Dosimetric uncertainties in the delivery of breast radiotherapy. Clinical Oncology , 13 (2) S2-.

Venables, K; Winfield, E; Deighton, A; Aird, E; Hoskin, P; (2001) The START Trial - measurements in semi-anatomical breast and chest wall phantoms. Physics in Medicine and Biology , 46 (7) pp. 1937-1948.

Venables, K; Winfield, E; Deighton, A; Aird, E; Hoskin, P; (2001) A survey of radiotherapy quality control practice in the United Kingdom for the START trial. Radiotherapy And Oncology , 60 (3) pp. 311-318.

Vieira, SAD; Deininger, MWN; Sorour, A; Sinclair, P; Foroni, L; Goldman, JM; Melo, JV; (2001) Transcription factor BACH2 is transcriptionally regulated by the BCR/ABL oncogene. GENES CHROMOSOMES & CANCER , 32 (4) pp. 353-363. 10.1002/gcc.1200.

Vig, S; Chitolie, A; Maurice, E; Boa, F; Bevan, DH; Halliday, A; Dormandy, J; (2001) Poor outcome following revascularization predicted by thromboelastography. BRIT J SURG , 88 (4) 621 - 622.

Virchis, A; Massey, E; Butler, T; Devaraj, P; Wright, F; Secker-Walker, L; Prentice, HG; (2001) Acute myeloblastic leukaemias of FAB types M6 and M4, with cryptic PML/RAR alpha fusion gene formation, relapsing as acute promyelocytic leukaemia M3. British Journal of Haematology , 114 (3) pp. 551-556.

Vorechovsky, I; Kralovicova, J; Laycock, MD; Webster, ADB; Marsh, SGE; Madrigal, A; Hammarstrom, L; (2001) Short tandem repeat (STR) haplotypes in HLA: an integrated 50-kb STR/linkage disequilibrium/gene map between the RING3 and HLA-B genes and identification of STR haplotype diversification in the class III region. EUROPEAN JOURNAL OF HUMAN GENETICS , 9 (8) pp. 590-598. 10.1038/sj.ejhg.5200688.

W

Wald, NJ; Hackshaw, AK; (2001) Folic acid and miscarriage: An unjustified link. AM J MED GENET , 98 (2) 204 - 204.

Walker, AE; Hall-Craggs, MA; Pringle, J; Whelan, JS; Witt, JD; Cobb, JP; (2001) MR-guided percutaneous biopsy of primary bone and soft-tissue tumors. In: (pp. p. 559). RADIOLOGICAL SOC NORTH AMERICA

Wardman, P; Folkes, LK; Bentzen, SM; Stratford, MRL; Hoskin, PJ; Phillips, H; Jackson, S; (2001) Influence of plasma glutathione levels on radiation mucositis. International Journal of Radiation Oncology Biology Physics , 51 (2) pp. 460-464.

Webley, SD; Francis, RJ; Pedley, RB; Sharma, SK; Begent, RHJ; Hartley, JA; Hochhauser, D; (2001) Measurement of the critical DNA lesions produced by antibody-directed enzyme prodrug therapy (ADEPT) in vitro, in vivo and in clinical material. BRIT J CANCER , 84 (12) 1671 - 1676. 10.1054/bjoc.2001.1843.

Wendy, V; (2001) Thalidomide could treat lung cancer. Metro 9-.

Wharton, SB; Chan, KK; Anderson, JR; Stoeber, K; Williams, GH; (2001) Replicative Mcm2 protein as a novel proliferation marker in oligodendrogliomas and its relationship to Ki67 labelling index, histological grade and prognosis. NEUROPATH APPL NEURO , 27 (4) 305 - 313.

Whelan, JS; Cassoni, AM; Cobb, JP; (2001) Bone. In: Price, P and Sikora, K, (eds.) Treatment of Cancer. : London.

Whelan, JS; Driver, D; Brock, C; McTiernan, A; Hamilton, C; Michelagnoli, M; (2001) Hepatic veno-occlusive disease complicating high dose chemotherapy for Ewing’s sarcoma. In:

Whelan, JS; Riley, V; (2001) Navigating in difficult waters: the care of teenagers with advanced cancer. In:

Wickremasinghe, RG; Ganeshaguru, K; Jones, DT; Lindsay, C; Spanswick, VJ; Hartley, JA; Wadhwa, M; ... Mehta, AB; + view all (2001) Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lymphocytic leukaemia cells. BRIT J HAEMATOL , 114 (3) 608 - 615.

Wickremasinghe, RG; Ganeshaguru, K; Jones, DT; Lindsay, C; Spanswick, VJ; Hartley, JA; Wadhwa, M; ... Mehta, AB; + view all (2001) Autologous plasma activates Akt/protein kinase B and enhances basal survival and resistance to DNA damage-induced apoptosis in B-chronic lymphocytic leukaemia cells. Br J Haematol , 114 (3) pp. 608-615.

Wilson, E; Makris, A; Novell, IR; (2001) Implementation of the two week rule has little effect on diagnostic yield in colorectal cancer. In: (pp. S121-).

Wilson, GD; Saunders, MI; Dische, S; Richman, PI; Daley, FM; Bentzen, SM; (2001) bcl-2 expression in head and neck cancer: An enigmatic prognostic marker. International Journal of Radiation Oncology Biology Physics , 49 (2) pp. 435-441.

Winfield, E; Venables, K; Aird, E; Hoskin, PJ; (2001) Film dosimetry, at depth, of the matchplane between breast tangential fields and anterior supraclavicular fossa field. In: (pp. S206-).

Winfield, E; Venables, K; Aird, E; Hoskin, PJ; (2001) In vivo disimertry for patients in the START Trial. In: (pp. S209-).

Wong, TF; Kini, M; Morris, R; Rolfe, KJ; Gammell, SJ; Crow, J; Reid, WMN; ... Perrett, CW; + view all (2001) Angiogenesis in primary epithelial ovarian carcinomas. In: (pp. pp. 1662-1663).

Wong, TF; Rolfe, KJ; Crow, J; Reid, WMN; MacLean, AB; Perrett, CW; (2001) Angiogenic growth factor expression in vulval tissues. In:

This list was generated on Sun Apr 15 02:50:00 2018 BST.